Patients Helping Patients
PF Warriors is pleased to invite you to an upcoming meeting featuring key updates on pulmonary fibrosis (PF) research.
Our distinguished speakers, Dr. Paul Noble and Dr. Tanzira Zaman from Cedars-Sinai, will provide an update on the Zinc Protocol for pulmonary fibrosis and introduce the Phase 1 Atezolizumab Study for PF patients.
Two years ago, Dr. Paul Noble presented to PF Warriors about a treatment that could potentially improve the regenerative capacity of fibrotic lung cells. We are looking forward to hearing the latest update.
Whether you are new to clinical trials or have prior experience, this presentation will provide valuable insights into the future treatment options for pulmonary fibrosis (PF). Join Drs. Paul Noble, MD, and Tanzira Zaman, MD, as they discuss updates on the Zinc Protocol and introduce us to the Phase 1 Atezolizumab Study for pulmonary fibrosis (PF).
Topics to be discussed:
Become a PF Warriors Member!
Membership is always FREE! By becoming a member of the PF Warriors community, you will gain exclusive access to incredible resources designed to support and empower you on your journey with pulmonary fibrosis.
As a member, you will:
What is Pulmonary Fibrosis?
Pulmonary fibrosis is a progressive lung disorder characterized by the formation of scar tissue in the lungs. This scarring leads to breathing difficulties, diminished lung function, and lower oxygen levels in the bloodstream. While currently incurable, there are treatments available to manage symptoms and improve quality of life.